An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug...

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Formulation Development

Background:

• Self-microemulsifying drug delivery systems (SMEDDS) offer improved solubility and bioavailability for poorly water-soluble drugs.
• Optimizing SMEDDS formulations is crucial for achieving desired drug release and absorption characteristics.
• Bufalin, a potent compound, requires effective delivery systems to maximize its therapeutic potential.

Purpose of the Study:

• To develop and optimize a novel self-microemulsifying drug delivery system (SMEDDS) for bufalin.
• To establish an efficient screening and optimization methodology for SMEDDS formulations.
• To evaluate the physicochemical properties, drug release, and in vivo absorption of the optimized bufalin SMEDDS.

Main Methods:

• Solubility studies and ternary phase diagram construction to identify optimal excipients.
• Experimental design combined with desirability studies for formulation optimization.
• Characterization of SMEDDS properties including droplet size, PDI, solubility, and drug release kinetics.
• Assessment of bufalin absorption across intestinal segments and relative bioavailability determination.

Main Results:

• An optimal bufalin SMEDDS formulation was successfully developed using Maisine 35-1, Miglyol 812N, Cremophor EL, and Transcutol P.
• The optimized SMEDDS exhibited a small droplet size (33.9 nm), low PDI (0.126), high equilibrium solubility (12.6 mg/ml), and good drug release (73.6% post-digestion).
• Bufalin SMEDDS demonstrated enhanced absorption in all intestinal segments, resulting in a 2.38-fold increase in relative bioavailability compared to bufalin suspension.

Conclusions:

• The integrated approach of solubility studies, ternary phase diagrams, and experimental design provides an efficient strategy for SMEDDS development and optimization.
• The developed bufalin SMEDDS formulation significantly improves drug absorption and bioavailability, offering a promising delivery system for bufalin.
• This methodology can be broadly applied to optimize various SMEDDS formulations for enhanced drug delivery.